Skip to content

Clinical trials

Phase 2/3 Carcinoma, Non-Small-Cell Lung trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2/3 Country / region: Spain Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20111
20121
20141
20171
20203
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Terminated3
Active, not recruiting2
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Hoffmann-La Roche2
BioNTech SE1
Bristol-Myers Squibb1
Clovis Oncology, Inc.1
Eikon Therapeutics1
GlaxoSmithKline1
Mirati Therapeutics Inc.1
NCIC Clinical Trials Group1
Synta Pharmaceuticals Corp.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung13
Lung Neoplasms4
Neoplasms2
Neoplasm Metastasis1
Recurrence1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.